NCT06312904

Paravertebral Block for Postoperative Analgesia in Children Undergoing Lateral Incision Cardiac Surgery With CBP

Name: Clinical Trial NCT06312904
Creator: Chinese Academy of Medical Sciences, Fuwai Hospital
Keywords: Postoperative Pain, paravertebral block, procedure, clinical trial

Effects of Paravertebral Block on Postoperative Analgesia in Children Undergoing Lateral Incision Cardiac Surgery With Cardiopulmonary Bypass: a Randomized Controlled Trial

Chinese Academy of Medical Sciences, Fuwai Hospital·ClinicalTrials.gov·procedureNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Postoperative Pain
Drug/Device/Intervention: paravertebral block
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital

Timeline & enrollment

Phase: N/A
Start date: Mar 11, 2024
End date: Dec 30, 2024
Enrollment: 100 participants

Primary outcome

opioid consumption during the first 24h after surgery

Summary

This study aims to compare the effect of paravertebral block and local infiltration anesthesia on postoperative analgesia in children undergoing lateral incision cardiac surgery with cardiopulmonary bypass. The researchers hope to investigate whether children who undergo paravertebral block experience less postoperative pain, have fewer postoperative complications, and recover more quickly.

ICD-10 classifications

Acute painPostoperative intestinal obstructionPain, unspecifiedDuring surgical operationDuring surgical operation

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06312904
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06312904 through Pure Global AI's free database. This phase not specified trial is sponsored by Chinese Academy of Medical Sciences, Fuwai Hospital and is currently Not yet recruiting. The study focuses on Postoperative Pain. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.